Tag: Endolysin

iNtRON completes the sponsorship transfer process for the US Phase 2 study of SAL200

Press Release Aug 23, 2022

▶ To maintain the US FDA-approved IND for the future out-licensing deal ▶ Plan to proceed Phase 2 with a new out-licensing partnership ▶ AMR problem became much more serious than ever ▶ SAL200 will be AMR solution as a […]